Delivery Order SPE2DB25D3008-SPE2DB25FRCTX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,724.25 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30, with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on July 24, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, for the supply of Modafinil 100 mg tablets in 30-count units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,476.93 with a firm fixed price structure and an ultimate completion date of July 30, 2025. The delivery order was issued on July 29, 2025, with performance taking place at the vendor's corporate...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,766.03 for Modafinil 100 mg tablets (30-count packages) with a firm fixed price structure and an ultimate completion date of September 16, 2025. This non-set-aside contract was competitively awarded and reflects AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to federal medical procurement systems. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (quantity 30s) under a firm fixed price contract. The contract, valued at $2,749.28, was competitively awarded without set-aside designation and carries an ultimate completion date of August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $7,494.46 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,106.80 to AmerisourceBergen Drug Corp for Modafinil 100 mg tablets (quantity: 30 units) on July 30, 2025, with completion scheduled for July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a ceiling value of $8,125.97. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count) under a firm fixed-price contract valued at $2,641.58. The award, issued on August 20, 2025, represents a non-competitive, non-set-aside delivery order with an ultimate completion date of August 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count) under a firm fixed-price contract valued at $3,748.11, with an ultimate completion date of May 5, 2025. This non-competitive delivery order represents a continuation of the pharmaceutical supply services that AmerisourceBergen provides to the federal government. The contract is issued under the company's parent Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,370.31 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRCTXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,690.40 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The prime IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical commodities. The DLA is implementing a strategic Pharmaceutical Prime Vendor Global Program Generation V initiative designed to establish multiple regional contracts with separate contractors, positioning AmerisourceBergen to continue serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/29/25 |